Last Posted: Oct 08, 2019
- Genome-wide germline correlates of the epigenetic landscape of prostate cancer
KE Houlahan et al, Nature Medicine, October 7, 2019 - Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer.
Sumanasuriya Semini et al. European urology oncology 2018 1(2) 151-159 - Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations.
Bancroft Elizabeth K et al. BJU international 2019 123(2) 284-292 - Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.
Barcel? Maria et al. Scientific reports 2019 Sep 9(1) 13772 - [Genetic profiling in the diagnosis of hereditary prostate cancer: Where do we stand?]
Boehm Katharina et al. Aktuelle Urologie 2018 Dec 49(6) 525-529 - A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.
Georgescu Constantin et al. BMC cancer 2019 May 19(1) 423 - Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study.
Aggarwal Rahul et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 36(24) 2492-2503 - Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer.
Hennigan S Thomas et al. JCO precision oncology 2019 3 - Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing.
Greenberg Samantha et al. Cancer medicine 2019 Sep - Automatic segmentation of prostate MRI using convolutional neural networks: Investigating the impact of network architecture on the accuracy of volume measurement and MRI-ultrasound registration.
Ghavami Nooshin et al. Medical image analysis 2019 Sep 58101558
.png)
No hay comentarios:
Publicar un comentario